Eli Lilly said it iwa also in discussions with several other Indian manufacturers for the potential grant of additional voluntary licenses.from Moneycontrol Business News https://ift.tt/3y12ovK
Sunday, May 9, 2021
COVID-19 treatment: Eli Lilly partners with Cipla, Lupin, Sun Pharma to manufacture, distribute Baricitinib in India
Eli Lilly said it iwa also in discussions with several other Indian manufacturers for the potential grant of additional voluntary licenses.from Moneycontrol Business News https://ift.tt/3y12ovK
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment